12:00 AM
 | 
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Management Tracks

TiGenix board of directors update

TiGenix N.V. (Euronext:TIG), Leuven, Belgium
Business: Musculoskeletal, Gene/Cell therapy...

Read the full 23 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >